Newstral
Daniel Skovronsky
- TThe Dangers of Ozempic/Wegovytheava.com
- The race is on to stop Ozempic muscle lossThe New York Times
- Groundbreaking Alzheimer’s drug slows disease: A ‘new era’ for treatmentNew York Post
- 'Remarkable' Alzheimer drug reduces cognitive decline, test results showtimesofmalta.com
- WAlzheimer's drug candidate from Eli Lilly delivers 'the kind of efficacy that's never been seen before'wraltechwire.com
- World ‘on cusp of first treatments for Alzheimer’s disease’ after drug trialShropshire Star
- World ‘on cusp of first generation of treatments for Alzheimer’s’expressandstar.com
- MEli Lilly therapy with donanemab slowed illness developmentmvtelegraph.com
- Obesity treatments catch drugmakers’ eyes as sales seen soaringpressherald.com
- Obesity treatments the new $40b pharma frontierSydney Morning Herald
- MLilly's experimental weight-loss drug may be a 'multibillion-dollar opportunity'4 min readmarketwatch.com
- CF.D.A. Clears Monoclonal Antibody Drug From Eli Lillycentralrecorder.com
- FDA authorizes new Covid-19 monoclonal antibody that works against Omicron variantCNN
- FDA grants emergency authorization to new Eli Lilly antibody therapy for use against omicronstaradvertiser.com
- Biden admin moves to avoid shortages of monoclonal antibody treatmentsCNN
- BEli Lilly May Be a Big Winner From FDA's Alzheimer's Decision4 minbarrons.com
- The Race To Keep Antibody Treatments One Step Ahead Of Covid-19 VariantsForbes
- Lilly Seeks to End U.S. Use of Single Covid-19 Antibody Drug Alonewsj.com
- MU.S. COVID death toll nears 550,000 as Dr. Birx says most could have been avoidedmarketwatch.com
Frequent names
Newstral's extraction of names of people and organisations from the world's news is completely automated. If you do not want your name to appear here, please contact us. We will be happy to look at your request.